Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00515255 · ClinicalTrials.gov registry record · Phase 2
Study of NPL-2003 in Adolescents With Obsessive Compulsive Disorder (OCD)
A Phase 2 study, sponsored by Neuropharm.
- Terminated
- Registry status
- Phase 2
- Development phase
- 6
- Enrollment target
NCT00515255 is a Phase 2 study that was terminated before completion, run by Neuropharm. The registered enrollment target is 6 participants.
The verdict
NCT00515255, a Phase 2 study, was terminated before completion, sponsored by Neuropharm.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 6 participants
- Enrollment target
Study Summary
The purpose of this study is to investigate the effect of NPL-2003 on the symptoms of Obsessive Compulsive Disorder (OCD) in an adolescent population.
Interventions
- DRUG Minocycline
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2007-07 |
| Est. Completion | 2008-04 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00515255
The ClinicalTrials.gov registry entry for NCT00515255 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Neuropharm, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Minocycline is the first listed.
NCT00515255 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00515255 about?
NCT00515255 is a clinical study titled "Study of NPL-2003 in Adolescents With Obsessive Compulsive Disorder (OCD)". The purpose of this study is to investigate the effect of NPL-2003 on the symptoms of Obsessive Compulsive Disorder (OCD) in an adolescent population.
What is the current status of trial NCT00515255?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 6 participants. The study started on 2007-07. Estimated completion is 2008-04.
What interventions are being tested in trial NCT00515255?
The interventions under investigation include: Minocycline (DRUG).
Who is sponsoring clinical trial NCT00515255?
This trial is sponsored by Neuropharm, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.